MDxHealth (R)
Published: 07:00 CEST 02-05-2017 /GlobeNewswire /Source: MDxHealth (R) / : MDXH /ISIN: BE0003844611
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION
IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, May 2, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that MediNcrease Health Plans, a national provider network in the US, has signed a contract to make ConfirmMDx® for Prostate Cancer and SelectMDx(TM) for Prostate Cancer available to 5.5 million covered lives through its clients and payers.
"The ongoing US adoption of ConfirmMDx and SelectMDx for Prostate Cancer reinforces the value of the tests to improve patient outcomes while reducing healthcare costs," said Dr. Jan Groen, CEO of MDxHealth.
"We are thrilled to welcome MDxHealth, a global leader in the diagnosis and treatment of cancer, to the MediNcrease Provider Network," said Linda Plaster, CEO of MediNcrease Health Plans. "This exciting relationship affirms continued commitment to our specialty provider network expansion."